In this article, we provide now stringent evidence that microglia are target cells for NGF, both in vitro and ex vivo and that the activity carried out by this neurotrophin on microglial cells might result neuroprotective and anti‐inflammatory in the context of Alzheimer's disease. The gene discussed is NGF; the disease is Alzheimer disease.